Peregrine Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.99M | Sell |
288,636
-20,554
| -7% | -$569K | 0.24% | 115 |
|
|
2025
Q1 | $6.87M | Buy |
309,190
+65,147
| +27% | +$1.45M | 0.23% | 125 |
|
|
2024
Q4 | $4.83M | Buy |
244,043
+4,361
| +2% | +$86.3K | 0.14% | 227 |
|
|
2024
Q3 | $5.99M | Buy |
239,682
+526
| +0.2% | +$13.1K | 0.18% | 179 |
|
|
2024
Q2 | $4.47M | Buy |
239,156
+3,111
| +1% | +$58.1K | 0.13% | 237 |
|
|
2024
Q1 | $4.66M | Buy |
+236,045
| New | +$4.66M | 0.13% | 238 |
|